Researchers writing in Arthritis Research and Therapy describe the results of a randomized clincal trial in which most patients with Ankylosing spondylitis maintained low disease activity or remission with standard or reduced TNFi dose schedules.
A market analysis shows that bisphosphonates will reach $14 billion in sales by 2021. As more patients are prescribed these osteoporosis drugs, physicians will increasingly be faced with managing drug-related adverse events. Learn more in this article.
"Nearly one-third of pre‐surgical osteoarthritis patients used prescription opioid medication. Given the questionable efficacy of opioids in OA and risk of adverse effects, higher opioid use among younger individuals and those with depressive symptoms is of concern and warrants further investigation," researchers write in the January 10 issue of Arthritis Care and Research.
Abnormal nail folds with a pattern indicating systemic sclerosis (SSc) is common in patients with Raynaud's syndrome, shows a study recently published in the Journal of Rheumatology. It can also be present in patients with other forms of connective tissue disease, such as primary Sjögren syndrome, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease. An SSc abnormal nail growth pattern was also found to be associated with abnormal pulmonary function tests (PFT). Learn more here in this slideshow.
The focus here: early signs and symptoms that can point to the diagnosis.
(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia predicts mortality.
French researchers identified a specific phenotype along with predictive factors.
This meta-analysis confirms and clarifies the link between SLE and certain types of cancer.
While traditional risk factors play a role, factors specific to SLE also contribute to CVD.
Researchers identify influential factors on hand function in rheumatoid arthritis.